According to Celltrion, Steqeyma was approved based in part on the findings of a Phase III study in plaque psoriasis, which demonstrated that the biosimilar had no clinically meaningful differences versus Stelara in terms of efficacy or safety
OACs guiding principle has always been that obesity medications should be evidence-based, FDA-approved and covered by health insurance
Maternal choline is important for neural tube closure in the fetus and for neurodevelopment in the fetal hippocampus, which effects memory
The Lancet, 402 (10401), 529544
Markey KA, Ottridge R, Mitchell JL et al (2017) Assessing the Efficacy and Safety of an 11beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) in the Idiopathic Intracranial Hypertension Drug Trial, IIH:DT: Clinical Methods and Design for a Phase II Randomized Controlled Trial
We will continue to research and update you on what the studies are showing